How OneLegacy’s XVIVO EVLP center could expand access to transplantable donor lungs
OneLegacy’s new Western U.S. EVLP hub brings XVIVO lung perfusion closer to donor recovery, with major implications for transplant access.
Medical Devices & Diagnostics
Medical Devices & Diagnostics
C2N Diagnostics gains Anthem coverage for PrecivityAD2 blood-based Alzheimer’s evaluation
Anthem will cover C2N Diagnostics’ PrecivityAD2 from October 2026. Read what the move means for Alzheimer’s blood testing access.
Medical Devices & Diagnostics
FDA clears Zeta’s robotic TMS system, but the real test begins inside busy clinics
Zeta Surgical wins FDA clearance for its robotic TMS system, advancing automated coil positioning and motion compensation in neuromodulation clinics.
Medical Devices & Diagnostics
Why the PDV MedTech and Corscience partnership could help medtech startups reach production
PDV MedTech and Corscience GmbH & Co. KG have formed a strategic partnership intended to give medical-device companies a more connected route from early product development through regulatory preparation, manufacturing scale-up and commercialization. The alliance combines Corscience’s engineering experience in complex and safety-critical systems with PDV MedTech’s manufacturing operations in the United States and its
Medical Devices & Diagnostics
VB Spine opens European distribution hub in France to accelerate spine device deliveries
VB Spine has begun shipping spine surgery products from its newly operational European distribution centre in Cestas, France, giving the privately held medical technology company a more direct logistics base for serving hospitals and clinical customers across the region. The facility, which started accepting orders on June 1, 2026, became fully operational in July and
Medical Devices & Diagnostics
Why the AccurKardia and Wellysis partnership matters for digital cardiology adoption
AccurKardia, Inc. and Wellysis have signed a multi-year agreement to provide a turnkey cardiac monitoring offering for the United States market. The arrangement will pair Wellysis’ S-Patch wearable ECG monitor with AccurKardia’s AccurECG 2.0 automated analytics and reporting software, creating a combined workflow for Holter, extended Holter and mobile cardiac telemetry services. The deal is
Medical Devices & Diagnostics
Leo Cancer Care targets proton therapy access with $65m Series D financing
Leo Cancer Care has raised $65 million in Series D financing to scale its integrated upright cancer care platform, which is designed to image and treat patients in a seated position rather than the conventional lying-down setup. The oversubscribed round supports manufacturing scale-up, commercial deployment and continued development across upright proton therapy, photon therapy and
Medical Devices & Diagnostics
Conavi Medical builds case for hybrid IVUS-OCT imaging in complex PCI
Conavi Medical Corp. has announced a peer-reviewed case publication highlighting the use of its hybrid intravascular ultrasound and optical coherence tomography imaging system in a complex coronary intervention involving a patient with impaired renal function. The publication follows U.S. Food and Drug Administration 510(k) clearance for the Canadian medical device developer’s next-generation hybrid IVUS-OCT imaging
Medical Devices & Diagnostics
ReCET trial enrollment puts Endogenex in focus for gut-targeted diabetes care
Endogenex has completed enrollment in the ReCET Clinical Study, a pivotal evaluation of the Endogenex System in adults with type 2 diabetes whose blood glucose levels remain inadequately controlled on non-insulin glucose-lowering medications. The study has enrolled 350 patients across approximately 40 sites in the United States and Australia, moving the clinical-stage medical device developer
Medical Devices & Diagnostics
What iHealthScreen’s iPredict-DR clearance changes for diabetes clinics and primary care
iHealthScreen Inc. has received U.S. Food and Drug Administration 510(k) clearance for iPredict-DR, an AI-powered Software as a Medical Device for automated diabetic retinopathy screening. The retinal imaging software detects more than mild diabetic retinopathy in adults with diabetes who have not previously been diagnosed with the condition, placing the healthcare AI developer into a